a65006

Lansoprazole (A-65006) is a 2, 2, 2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)

Lansoprazole-D4 is a deuterium labeled Lansoprazole. Lansoprazole (T0674) is an inhibitor of proton pump which prevents the stomach from producing acid.

Lansoprazole-[13C6] (Standard) is a reference standard of Lansoprazole-[13C6] intended for quantitative analysis, quality control, and related biochemical research applications.

Lansoprazole sodium (Lansoprazole (sodium)) is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity which is widely used in the therapy of gastroesophageal reflux and peptic ulcer disease.

Lansoprazole (Standard) is the standard substance of Lansoprazole, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Lansoprazole (A-65006) is a 2, 2, 2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)

(R)-Lansoprazole-D4 is the deuterium-labeled form of  (R)-Lansoprazole (T1021). This compound is the R-enantiomer of Lansoprazole, a proton pump inhibitor that suppresses gastric acid production. Additionally, Lansoprazole (AG 1749) acts as an inhibitor of neutral sphingomyelinase (N-SMase), functioning as an exosome inhibitor.

Levolansoprazole ((S)-Lansoprazole), a proton pump inhibitor, irreversibly inhibits H+/K+-stimulated ATPase pumps in parietal cells (IC50: 5.2 μM). It also inhibits acid formation in isolated canine parietal cells (IC50: 82 μM). Both (R)- and (S)-lansoprazole are pharmacologically active with similar potencies.

(R)-Lansoprazole (T 168390) is the R-isomer of lansoprazole and a substituted benzimidazole prodrug with selective and irreversible proton pump inhibitor activity.Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)